UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
V2X
VVX
$2.65B
| $848K | ﹤0.01% |
20,543
-5,393
| -21% | -$214K |
|
1877
International Money Express
IMXI
$358M
| $848K | ﹤0.01% |
34,780
+7,946
| +30% | +$182K |
|
1878
Virgin Galactic
SPCE
$398M
| $847K | ﹤0.01% |
12,168
+922
| +8% | +$86K |
|
1879
Varex Imaging
VREX
$776M
| $846K | ﹤0.01% |
41,681
-5,787
| -12% | -$121K |
|
|
HAPN
1880
Happen Inc
HAPN
$2.26B
| $846K | ﹤0.01% |
96,140
+2,747
| +3% | +$28.3K |
|
|
XRN
1881
Chiron Real Estate Inc
XRN
$475M
| $845K | ﹤0.01% |
17,833
+1,204
| +7% | +$54.4K |
|
|
SQSP
1882
DELISTED
Squarespace, Inc.
SQSP
| $845K | ﹤0.01% |
38,104
| – | – |
|
1883
Heartland Express
HTLD
$926M
| $845K | ﹤0.01% |
55,064
+8,597
| +19% | +$133K |
|
|
AGNT
1884
AGNT Inc
AGNT
$710M
| $844K | ﹤0.01% |
76,217
-4,108
| -5% | -$49.8K |
|
|
VTLE
1885
DELISTED
Vital Energy
VTLE
| $842K | ﹤0.01% |
16,379
-36
| -0.2% | -$2.22K |
|
1886
Dutch Bros
BROS
$9B
| $841K | ﹤0.01% |
29,831
+9,904
| +50% | +$328K |
|
1887
iShares MSCI Philippines ETF
EPHE
$147M
| $841K | ﹤0.01% |
32,100
| – | – |
|
1888
Pitney Bowes
PBI
$2.36B
| $838K | ﹤0.01% |
220,650
-11,033
| -5% | -$37.2K |
|
|
FORG
1889
DELISTED
ForgeRock, Inc.
FORG
| $835K | ﹤0.01% |
36,689
-133,855
| -78% | -$2.92M |
|
1890
Gogo Inc
GOGO
$468M
| $834K | ﹤0.01% |
56,536
| – | – |
|
1891
VEON
VEON
$3.92B
| $833K | ﹤0.01% |
68,008
| – | – |
|
1892
Hillman Solutions
HLMN
$1.77B
| $833K | ﹤0.01% |
115,541
| – | – |
|
1893
Standard Motor Products
SMP
$897M
| $832K | ﹤0.01% |
23,904
-1,347
| -5% | -$49.3K |
|
1894
Green Brick Partners
GRBK
$3.02B
| $832K | ﹤0.01% |
34,331
| – | – |
|
1895
Coherus Oncology
CHRS
$201M
| $831K | ﹤0.01% |
104,974
+48,472
| +86% | +$373K |
|
|
ARCH
1896
DELISTED
Arch Resources, Inc.
ARCH
| $827K | ﹤0.01% |
5,793
| – | – |
|
1897
Recursion Pharmaceuticals
RXRX
$1.79B
| $824K | ﹤0.01% |
106,931
+30,052
| +39% | +$295K |
|
1898
Vericel Corp
VCEL
$2.28B
| $824K | ﹤0.01% |
31,274
| – | – |
|
1899
Keros Therapeutics
KROS
$217M
| $823K | ﹤0.01% |
17,135
| – | – |
|
1900
Enviri
NVRI
$625M
| $823K | ﹤0.01% |
130,786
+36,716
| +39% | +$219K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.